Company attributes
B2X
CEO
Founder
Pitchbook URL
Number of Employees (Ranges)
1 – 10
Full Address
3210 Merryfield Row San Diego, CA 92121
DUNS Number
081266832
Total Funding Amount (USD)
817,000
Latest Funding Round Date
September 2019
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Founded in 2018, Navega Therapeutics Inc. is a preclinical stage company pursuing an approach to treat chronic pain and tackle the opioid epidemic via a gene therapy platform.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.